Nath Bio-Genes (India) (BOM:537291) Other Stockholders Equity: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:537291 Nath Bio-Genes (India) Ltd BOM:537291
71 GF Score
Price ₹155.55
GF Value ₹262.61
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Nath Bio-Genes (India) Other Stockholders Equity?

Nath Bio-Genes (India) BOM:537291 -1.49% 71 Other Stockholders Equity is ₹0 Mil as of Jun. 2026. GuruFocus rates BOM:537291 with a GF Score™ of 71/100 and a GF Value™ of ₹262.61 (Possible Value Trap). The stock has 4 warning signs investors should review.

Nath Bio-Genes (India)'s Other Stockholders Equity for the quarter that ended in Jun. 2026 was ₹0 Mil.

Nath Bio-Genes (India)'s quarterly Other Stockholders Equity increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹6,615 Mil) but then declined from Mar. 2026 (₹6,615 Mil) to Jun. 2026 (₹0 Mil).

Nath Bio-Genes (India)'s annual Other Stockholders Equity declined from Mar. 2024 (₹150 Mil) to Mar. 2025 (₹147 Mil) but then increased from Mar. 2025 (₹147 Mil) to Mar. 2026 (₹6,615 Mil).

Nath Bio-Genes (India) Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Nath Bio-Genes (India)'s Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nath Bio-Genes (India) Other Stockholders Equity Chart

Nath Bio-Genes (India) Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 140.70 140.90 150.18 146.87 6,614.55

Nath Bio-Genes (India) Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 6,608.49 0.00 6,614.55 0.00
BOM:537291
71GF Score
Nath Bio-Genes (India) Ltd BOM:537291
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nath Bio-Genes (India) Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of ₹0 Mil mean?
Nath Bio-Genes (India) (BOM:537291) has a Other Stockholders Equity of ₹0 Mil as of Jun. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Nath Bio-Genes (India) and its competitors.
Is Nath Bio-Genes (India)'s Other Stockholders Equity too high?
Nath Bio-Genes (India)'s current Other Stockholders Equity is ₹0 Mil. Overall, Nath Bio-Genes (India) has a GF Score™ of 71/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nath Bio-Genes (India)'s Other Stockholders Equity compare to CTVA and CF?
Nath Bio-Genes (India)'s Other Stockholders Equity of ₹0 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for an Agriculture company?
A good Other Stockholders Equity depends on the Agriculture industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Nath Bio-Genes (India) and its competitors. Nath Bio-Genes (India)'s current Other Stockholders Equity is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nath Bio-Genes (India) stock overvalued right now?
Based on GuruFocus' analysis, Nath Bio-Genes (India) (BOM:537291) is currently considered Possible Value Trap. The stock's GF Value™ is ₹262.61, compared to a current price of ₹155.55 — trading 40.8% below its estimated fair value. The current Other Stockholders Equity is ₹0 Mil. Nath Bio-Genes (India)'s overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Nath Bio-Genes (India) (BOM:537291), the current Other Stockholders Equity is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nath Bio-Genes (India) (BOM:537291) Overvalued in 2026?

Based on GuruFocus' analysis, Nath Bio-Genes (India) stock appears to be undervalued. The current stock price of ₹155.55 is trading 40.8% below its estimated GF Value™ of ₹262.61. GuruFocus considers Nath Bio-Genes (India) to be Possible Value Trap.

Key valuation signals for BOM:537291:

  • Other Stockholders Equity: ₹0 Mil
  • GF Value™: ₹262.61 vs. price of ₹155.55 (40.8% below fair value)
  • GF Score™: 71/100 with 4 warning signs

No single metric tells the full story. See the BOM:537291 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nath Bio-Genes (India) Business Description

Other Exchanges NATHBIOGEN:India
Address 86, Veer Nariman Road, 1, Chateau Windsor, Churchgate, Mumbai, MH, IND, 400 020
Nath Bio-Genes (India) Ltd is engaged in the business of production, processing, and marketing of Hybrid and GM seeds. The company has a product range of field crops, vegetable crops, and micronutrient supplements. It has developed products across verticals of cotton, paddy, mustard, maize, okra, tomato, gourds, chili, and crop nutrition supplements. The operating segments of the group are Agriculture activities; and Trading activities, of which a majority of revenue is derived from the Agriculture activities segment. Geographically, the group has a business presence in India and other countries, of which key revenue is generated within India.
71GF Score

Get the complete analysis for BOM:537291

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹155.55
Price
₹262.61
GF Value